510(k) · Cleared
ClearedAmicus Separator System/ Amicus Seperator System;Refurbished
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Fenwal, Inc. · LKN Separator, Automated, Blood Cell And Plasma, Therapeutic
Cleared on Jun 10, 2014 as substantially equivalent to K111702 (Fenwal, Inc., 2012) after a 50-day review. Its family tree reaches back 3 generations to 1981. 1 later device descends from it.
- Decided
- Jun 10, 2014
- Review
- 50 days
- Class
- Class U
- Product code
- LKN
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 3 generations to K811078 (1981). 5 ancestors in all. 1 later device descends from it, 1 citing it directly.
- Root · 3 generations backK811078 Radiation Sterilized Admin. SetTravenol Laboratories, S.A. · 1981 · Recalled
- 2 generations backK073339 Blood Component Recipient Set with Standard Size Filter and Infusion…Fenwal, Inc. · 2008
- 1 generation backK111702 Amicus Separator System- Use in Therapeutic Plasma Exchange and…Fenwal, Inc. · 2012 · Recalled
- This deviceK141019 Amicus Separator System/ Amicus Seperator System;RefurbishedFenwal, Inc. · 2014
- Descendant · cites it directly · 0 of its ownK162462 AMICUS Separator System, AMICUS Separator System; RefurbishedFresenius Kabi USA,Llc · 2016
Most influential descendants
Showing 1 of 1 · See all- K162462AMICUS Separator System, AMICUS Separator System; RefurbishedFresenius Kabi USA,Llc · 2016 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K811078 | Radiation Sterilized Admin. Set | Travenol Laboratories, S.A. | 1981 | 17 |
| −2 | K073339 | Blood Component Recipient Set with Standard Size Filter and Infusion Set with… | Fenwal, Inc. | 2008 | — |
| −1 | K111702 | Amicus Separator System- Use in Therapeutic Plasma Exchange and Filter Set for… | Fenwal, Inc. | 2012 | 1 |
| 0 (this device) | K141019 | Amicus Separator System/ Amicus Seperator System;Refurbished | Fenwal, Inc. | 2014 | — |
| +1 | K162462 | AMICUS Separator System, AMICUS Separator System; Refurbished | Fresenius Kabi USA,Llc | 2016 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1988 | 1 | 0 |
| 1991 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2016 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LKN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K111702 | Amicus Separator System- Use in Therapeutic Plasma Exchange and Filter Set for Amicus TpeSummary page 2…th the currently cleared version of the AMICUS Separator System. The AMICUS Separator System was most recently cleared for Therapeutic Plasma Exchange (TPE) under 510(k) K111702 on March 22, 2012. The AMICUS Separator System was most recently cleared for apheresis under 510(k) BK120082 on January 8, 2013.… | 2012 |
| Kept off the family tree | K120082 | AMICUS Separator System The summary prints BK120082, a CBER number, which our reading took as K120082, which is not in FDA’s 510(k) list. Kept off the family tree. Summary page 2…y cleared for Therapeutic Plasma Exchange (TPE) under 510(k) K111702 on March 22, 2012. The AMICUS Separator System was most recently cleared for apheresis under 510(k) BK120082 on January 8, 2013. This includes all operating protocols and changes previously cleared for the AMICUS Separator System. Device… |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K162462 | AMICUS Separator System, AMICUS Separator System; Refurbished | 2016 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 33 years and passes through 2 companies; a new generation was cleared every 4.1 years on median.
- 3 of the 5 ancestors have a recall of any class.
- Of its descendants, K162462 (Fresenius Kabi USA,Llc, 2016) has gone furthest, with 0 descendants of its own.
How does its category compare?
All LKN devicesLKN Separator, Automated, Blood Cell And Plasma, Therapeutic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.
FDA decisions per year · LKN
2in 2019
2026 to Oct 25, outlined.
Median 510(k) review, days · LKN
195in 2018
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LKN
1in 2012
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LKN
71in 2025
MAUDE reports naming product code LKN, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 1 | 10 |
| 2008 | 0 | — | 0 | 14 |
| 2009 | 0 | — | 0 | 18 |
| 2010 | 1 | — | 2 | 132 |
| 2011 | 0 | — | 3 | 481 |
| 2012 | 2 | — | 1 | 372 |
| 2013 | 2 | — | 0 | 96 |
| 2014 | 1 | — | 0 | 128 |
| 2015 | 2 | — | 0 | 306 |
| 2016 | 1 | — | 0 | 206 |
| 2017 | 0 | — | 0 | 169 |
| 2018 | 3 | 195 | 0 | 55 |
| 2019 | 2 | — | 0 | 72 |
| 2020 | 0 | — | 0 | 135 |
| 2021 | 0 | — | 0 | 63 |
| 2022 | 0 | — | 0 | 42 |
| 2023 | 0 | — | 0 | 132 |
| 2024 | 0 | — | 0 | 161 |
| 2025 | 0 | — | 0 | 71 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The AMICUS Separator System is an automated blood cell separator indicated to perform Therapeutic Plasma Exchange (TPE). The AMICUS Separator System is an automated blood cell separator indicated for the collection of blood components and mononuclear cells. The device is designed to collect products while maintaining an extracorporeal volume at or below 10.5 mL/kg and a donor post platelet count greater than or equal to 100,000 platelets/microliter.…
Read the full statement (309 words)
The AMICUS Separator System is an automated blood cell separator indicated to perform Therapeutic Plasma Exchange (TPE).
The AMICUS Separator System is an automated blood cell separator indicated for the collection of blood components and mononuclear cells.
The device is designed to collect products while maintaining an extracorporeal volume at or below 10.5 mL/kg and a donor post platelet count greater than or equal to 100,000 platelets/microliter.
Depending on the AMICUS Separator System apheresis kit used in the collection of products, the AMICUS Separator System has been cleared to collect:
* Platelets Pheresis, Leukocytes Reduced (single, double, or triple units)
* Platelets Pheresis, Leukocytes Reduced, Platelet Additive Solution (InterSol) (single, double or triple units)
* Red Blood Cells, Leukocytes Reduced (by apheresis)
* Mononuclear Cells
* Plasma
o Fresh Frozen Plasma
*Must be prepared and placed in a freezer at -18° C or colder within 8 hours after phlebotomy.
o Plasma Frozen Within 24 Hours After Phlebotomy (PF24)
* Must be stored at 1-6° C within 8 hours after phlebotomy and placed in a freezer at -18° C or colder within 24 hours after phlebotomy.
* Indicated for replacement of non-labile clotting factors. This product is not equivalent to Fresh Frozen Plasma.
o Plasma Frozen Within 24 Hours After Phlebotomy (PF24) Held at Room Temperature Up to 24 Hours After Phlebotomy (PF24RT24)
* Can be stored at room temperature for up to 24 hours after phlebotomy. Product must be placed in a freezer at -18° C or colder within 24 hours after phlebotomy.
* Indicated for replacement of non-labile clotting factors. This product is not equivalent to Fresh Frozen Plasma.
o Source Plasma
Platelet Pheresis (single, double, or triple units) may be manufactured from products that do not meet leukocyte reduction product standards. This does not apply to Platelet Pheresis, Platelet Additive Solution (InterSol) (single, double, or triple units).
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K141019 · printed Nov 6, 2026
Cite this page
510(k) Report. “K141019: Amicus Separator System/ Amicus Seperator System;Refurbished.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K141019
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026